News

About 15% of colon cancers are dMMR, which confers resistance to chemotherapy. ICIs have FDA approval for metastatic dMMR ...
Eli Lilly's gene-silencing drug lepodisiran has ... inhibitor from China's Jiangsu Hengrui Pharma for $200m upfront.